Jennifer Nam, | |
6150 Van Buren Blvd, Riverside, CA 92503-8014 | |
(951) 688-5155 | |
Not Available |
Full Name | Jennifer Nam |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 6150 Van Buren Blvd, Riverside, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568817245 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 72786 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jennifer Nam, 6150 Van Buren Blvd, Riverside, CA 92503-8014 Ph: () - | Jennifer Nam, 6150 Van Buren Blvd, Riverside, CA 92503-8014 Ph: (951) 688-5155 |
News Archive
EPIRUS Biopharmaceuticals, Inc., formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade in a single dose comparator trial.
Researchers from The Cancer Institute of New Jersey are converging on Washington, D.C., this week for the 101st Annual Meeting of the American Association for Cancer Research (AACR) to share their findings on how a common genetic variation can impact diagnosis of breast cancer in postmenopausal women.
Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 24, 2011.
Informatics Corporation of America (ICA), unmatched in its ability to deliver a cost-effective, proven solution that leverages complete data across clinical settings to aid decision-making and improve patient outcomes, announced that its CareAlign™ technology was selected by Tennessee-based Cumberland Pediatrics Independent Practice Association (CPIPA).
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.
› Verified 9 days ago
Vi T Dang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3849 Chicago Ave, Riverside, CA 92507 Phone: 951-684-7416 Fax: 951-684-4659 | |
Dr. Ian Rojas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9211 Shamouti Dr, Riverside, CA 92508 Phone: 951-552-5614 | |
Vy Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-5017 Fax: 951-353-4208 | |
Hayley Noelle Cliatt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9990 County Farm Rd Ste 2, Riverside, CA 92503 Phone: 951-358-4700 | |
Faria Seanpanah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8938 Trautwein Rd, Riverside, CA 92508 Phone: 951-656-3394 | |
Connie Chu Lee, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11080 Magnolia Ave, Riverside, CA 92505 Phone: 951-602-4137 | |
Dr. Kathleen A Dinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4790 La Sierra Ave, Riverside, CA 92505 Phone: 951-688-4196 Fax: 951-688-7822 |